Keizer et al.
1467
(w), 1259 (m), 1223 (m), 1190 (w), 1115 (m), 1018 (s), 981
(w), 915 (w), 876 (m), 769 (m), 697 (s), 642 (m). H NMR
IR (KBr pellet) (cm–1): 2952 (s), 2904 (w), 2862 (w), 1632
(s), 1573 (m), 1458 (m), 1433 (w), 1359 (w), 1295 (w), 1254
(m), 1215 (w), 1079 (w), 1010 (m), 974 (w), 847 (m), 771
1
(CDCl3) ꢀ: 1.29 (s, 18H, C(CH3)3), 1.43 (s, 18H, C(CH3)3),
2.75 (m, 2H, CH2), 4.09 (m, 4H, NCH2), 7.12 (d, 2H, C6H2),
7.73 (d, 2H, C6H2), 8.38 (s, 2H, N=CH). 13C NMR (CDCl3)
ꢀ: 29.6 (C(CH3)3), 30.0 (CH2), 31.4 (C(CH3)3), 34.6
(NCH2), 35.3 (NCH2), 54.8 (C(CH3)3), 115.7 (Ph), 126.2
(Ph), 135.4 (Ph), 139.8 (Ph), 144.2 (Ph), 154.7 (Ph), 164.9
(N=CH). 11B NMR (CDCl3) ꢀ: 6.05 (w1/2 = 46.7 Hz). MS
(%): 668 ([M]+, 2), 631 ([M – Cl], 100). Anal. calcd. for
B2C33H48N2O2Cl4: C 59.44, H 7.26, N 4.20; found: C 60.08,
H 7.82, N 3.96.
1
(m), 712 (s), 641 (w). H NMR (CDCl3) ꢀ: 1.27 (s, 18H,
C(CH3)3), 1.43 (s, 18H, C(CH3)3), 1.55 (m, 4H, CH2), 2.02
(m, 4H, CH2), 3.91 (m, 4H, NCH2), 7.18 (d, 2H, C6H2), 7.68
(d, 2H, C6H2), 8.19 (s, 2H, N=CH). 13C NMR (CDCl3) ꢀ:
25.7 (CH2), 29.5 (C(CH3)3), 31.1 (C(CH3)3), 34.3 (NCH2),
35.0 (NCH2), 54.4 (C(CH3)3), 125.2 (Ph), 125.6 (Ph), 128.1
(Ph), 129.0 (Ph), 134.6 (Ph), 154.6 (Ph), 163.4 (N=CH).
11B NMR (CDCl3) ꢀ: 6.39 (w1/2 = 28.2 Hz). MS (%): 673
([M – Cl], 100), 658 ([M – Cl – Me], 10), 638 ([M – 2Cl],
50). Anal. calcd. for B2C36H54N2O2Cl4: C 60.99, H 7.68,
N 3.95; found: C 61.40, H 8.04, N 3.66.
Salben(t-Bu)[BCl2]2 (3)
To a stirring solution of salben(t-Bu)[B(OMe)2]2 (0.5 g,
0.75 mmol) in toluene (50 mL) was added 1M BCl3 in
heptane (1.5 mL, 1.50 mmol). The reaction mixture was
stirred for 24 h. The solution was concentrated to 5 mL,
filtered, and dried. Yield: 0.41g (81%); mp 316–318°C
(dec.). IR (KBr pellet) (cm–1): 2949 (s), 2893 (w), 2862 (w),
1631 (s), 1574 (m), 1470 (w), 1405 (w), 1361 (w), 1254 (m),
1219 (m), 1204 (w), 1095 (w), 1018 (m), 1008 (m), 872 (s),
Dealkylation of the trimethylphosphate
In an NMR tube, trimethylphosphate was added to an
equimolar solution of the compound (1–5) in CDCl3 and
held at room temperature for 30 min and 24 h. The reaction
1
was monitored by H NMR (Table 2).
Addition of a Lewis base
1
In an NMR tube, 5 equiv of THF were added to a solution
771 (m), 743 (m), 705 (m), 641 (w). H NMR (CDCl3) ꢀ:
of 2 in CDCl3. 11B NMR (CDCl3) ꢀ: 6.04 (w1/2 = 52.6 Hz).
1.22 (s, 18H, C(CH3)3), 1.41 (s, 18H, C(CH3)3), 2.17 (m,
4H, CH2), 4.03 (m, 4H, NCH2), 7.20 (d, 2H, C6H2), 7.70 (d,
2H, C6H2), 8.21 (s, 2H, N=CH). 13C NMR (CDCl3) ꢀ: 26.7
(CH2), 29.6 (C(CH3)3), 31.1 (C(CH3)3), 34.2 (NCH2), 35.0
(NCH2), 52.5 (C(CH3)3), 125.3 (Ph), 125.9 (Ph), 128.2 (Ph),
129.0 (Ph), 137.8 (Ph), 154.5 (Ph), 164.2 (N=CH). 11B NMR
(CDCl3) ꢀ: 5.99 (w1/2 = 49.5 Hz). MS (%): 681 ([M]+, 2),
645 ([M – Cl], 100), 610 ([M – 2Cl], 20). Anal. calcd. for
B2C34H50N2O2Cl4: C 59.98, H 7.41, N 4.12; found: C 61.35,
H 7.36, N 4.01.
Conclusion
A range of chelated boron compounds have been synthe-
sized and fully characterized. They demonstrate that further
derivatization of boron alkoxide compounds with Salen are
possible and that some are active in the dealkylation of
trimethylphosphate. It has been demonstrated that 1–5 are
inefficient dealkylating compounds by comparison to the
bromide analogues (23). Future work in this area entails in-
creasing the activity of the boron chloride compounds and
broadening their use as Lewis acid activators.
Salpten(t-Bu)[BCl2]2 (4)
To a stirring solution of salpten(t-Bu)[B(OMe)2]2 (0.68 g,
1.00 mmol) in toluene (50 mL) was added 1M BCl3 in
heptane (2.0 mL, 2.0 mmol). The reaction mixture was
stirred for 24 h. The solution was concentrated to 5 mL, fil-
tered, and dried. Yield: 0.64g (98%); mp 261–262°C (dec.).
IR (KBr pellet) (cm–1): 2961 (s), 2869 (w), 1630 (s), 1575
(m), 1474 (m), 1437 (m), 1395 (w), 1363 (m), 1251 (m),
1217 (w), 1190 (w), 1135 (w), 1078 (m), 1025 (m), 914 (m),
Acknowledgements
This work was supported by the National Science Founda-
tion NSF-CAREER award (CHE 9816155). L.J.D. was sup-
ported by the National Science Foundation Research
Experiences for Undergraduates (NSF-REU) program (CHE
-0097668) in the summer of 2001. NMR instruments used in
this research were obtained with funds from the Chemical
Research Instrumentation Fund (CRIF) program of the
National Science Foundation (CHE 997841) and from the
Research Challenge Trust Fund of the University of Kentucky.
1
8749 (m), 771 (m), 731 (s), 644 (w). H NMR (CDCl3) ꢀ:
1.28 (s, 18H, C(CH3)3), 1.45 (s, 18H, C(CH3)3), 1.59 (m,
2H, CH2), 2.19 (m, 4H, CH2), 3.98 (m, 4H, NCH2), 7.19 (d,
2H, C6H2), 7.69 (d, 2H, C6H2), 8.19 (s, 2H, N=CH).
13C NMR (CDCl3) ꢀ: 23.4 (CH2), 29.2 (C(CH3)3), 29.5
(CH2), 31.2 (C(CH3)3), 34.3 (NCH2), 35.0 (NCH2), 54.2
(C(CH3)3), 115.3 (Ph), 125.8 (Ph), 134.7 (Ph), 139.5 (Ph),
143.7 (Ph), 154.2 (Ph), 163.7 (N=CH). 11B NMR (CDCl3) ꢀ:
5.90 (w1/2 = 37.6 Hz). MS (%): 696 ([M]+, 5), 659 ([M – Cl],
100), 624 ([M – 2Cl], 20). Anal. calcd. for B2C35H52N2O2Cl4:
C 60.49, H 7.55, N 4.03; found: C 60.48, H 8.56, N 3.82.
References
1. M.J. Harvey and D.A. Atwood. Chem. Rev. 101, 37 (2001).
2. L. Canali and D.C. Sherrington. Chem. Soc. Rev. 28, 85 (1999).
3. S.J. Dzugan and V.L. Goedken. Inorg. Chem. 25, 2858 (1986).
4. W.-H. Leung, E.Y.Y. Chan, E.K.F. Chow, I.D. Williams, and
S.-M. Peng. J. Chem. Soc. Dalton Trans. 1229 (1996).
5. M.A. Van Aelstyn, T.S. Keizer, D.L. Klopotek, S. Liu,
M. Munoz-Hernandez, P. Wei, and D.A. Atwood. Organo-
metallics, 19, 1796 (2000).
Salhen(t-Bu)[BCl2]2 (5)
To a stirring solution of salhen(t-Bu)[B(OMe)2]2 (1.0 g,
1.46 mmol) in toluene (50 mL) was added 1M BCl3 in
heptane (2.9 mL, 2.92 mmol). The reaction mixture was
stirred for 24 h. The solution was concentrated to 5 mL, fil-
tered, and dried. Yield: 0.91g (91%); mp 302–304°C (dec.).
6. M.S. Hill and D.A. Atwood. Eur. J. Inorg. Chem. 67 (1998).
7. D.A. Atwood, J.A. Jegier, and D. Rutherford. Bull. Chem.
Soc. Jpn. 70, 2093 (1997).
© 2002 NRC Canada